v3.23.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net income $ 819 $ 288
Reconciliations of net income to net cash used in operating activities:    
Depreciation and amortization 1,677 1,508
Non-cash lease expense 1,756 1,798
Investment amortization and losses recognized 237 336
Deferred Income taxes   25
Share-based compensation 1,928 1,830
Changes in certain operating assets and liabilities:    
Trade accounts receivable (24,175) (100,589)
Income taxes 112 223
Prepaid expenses and other (818) (1,633)
Accounts payable (2,880) (153)
Accrued payroll, payroll taxes and related benefits 13,944 85,897
Other accrued liabilities (2,372) 50
Workers' compensation claims liabilities (14,412) (16,894)
Safety incentives liability (265) (1,038)
Operating lease liabilities (1,819) (1,725)
Other assets and liabilities, net (247) (132)
Net cash used in operating activities (26,515) (30,209)
Cash flows from investing activities:    
Purchase of property, equipment and software (2,995) (6,754)
Proceeds from sales and maturities of investments 233 10,796
Purchase of restricted investments (1,725) (2,272)
Proceeds from sales and maturities of restricted investments 2,446 18,735
Net cash (used in) provided by investing activities (2,041) 20,505
Cash flows from financing activities:    
Payments on long-term debt   (3,510)
Repurchases of common stock (8,030) (8,575)
Common stock repurchased on vesting of stock awards (1,005) (185)
Dividends paid (2,067) (2,229)
Proceeds from exercise of stock options 339 411
Net cash used in financing activities (10,763) (14,088)
Net decrease in cash, cash equivalents and restricted cash (39,319) (23,792)
Cash, cash equivalents and restricted cash, beginning of period 107,378 78,629
Cash, cash equivalents and restricted cash, end of period $ 68,059 $ 54,837

Source